Loam Bio
Founded 2019 · 79 employees on LinkedIn · 18 known investors
Using microbes to draw down carbon into soils at scale.
Also known as Loam Bio Australia · Soil Carbon Co
Investors · 18
Also in the syndicate · 7
Funding
SEC filings, press & company announcements$73M disclosed across 1 of 3 rounds · 2022–2023
- $73MSeries BFeb 2023 · 4 sources
Lowercarbon Capital (lead), Wollemi Capital (lead), Acre Venture Partners, Clean Energy Finance Corporation, Clean Energy Finance Corporation (CEFC), GrainInnovate, Grok Ventures, Hawktail, Horizons Ventures, Main Sequence, Thistledown, Time Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Loam Bio is an Australian agricultural biotechnology company that develops microbial products intended to increase the amount of stable carbon stored in cropping soils. Its lead product, CarbonBuilder, is a fungal seed inoculum applied as a dry powder at sowing; when the seed germinates, the microbes bind carbon drawn down by the plant through photosynthesis with microaggregates in the soil, favouring recalcitrant (slow-decomposing) carbon fractions rather than labile carbon. The company states the approach also improves soil structure, nutrient retention, water outcomes and crop yields. CarbonBuilder is used with FurrowMate, Loam's precision air-injection application system, across crops including wheat, barley, canola and pulses, and is distributed through agricultural retailers in Australia.
Alongside the input product, Loam runs SecondCrop, a carbon project service through which growers can register and administer soil carbon projects. Loam assists with scheme registration and administration, land management strategy, and measurement and verification, removes the upfront costs typically associated with entering carbon markets, and offers the option to train and pay a grower's existing agronomist. The company reports that its first carbon credits have been issued under the Nicholson Project.
Loam's R&D spans a microbial library of more than 2,000 unique fungal and bacterial isolates collected from natural and managed landscapes in both hemispheres, screened through a four-tiered genetic, laboratory, controlled-environment and field process. The organisms used in products are not genetically modified. The company reports academic collaborations with Western Sydney University, the University of Queensland and Lawrence Livermore National Laboratory.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 6
launches, deals, and filingsLoam Bio announced the appointment of Rob Hranac as chief executive as the company entered a next phase of commercial growth.
Loam reported its first carbon credit result, with credits issued to grower Steve Nicholson under a SecondCrop project.
Series B round co-led by Lowercarbon Capital and Wollemi Capital, with Horizons Ventures, Acre Venture Partners, Main Sequence, the Clean Energy Finance Corporation, Grok Ventures and others participating. Funds earmarked for expanding the seed coating product and testing in new geographies.
$73M source ↗
Loam said it would expand field testing into new geographies including Canada and Brazil, focused on major crops grown in those regions, with US commercialisation planned for 2024.
Loam commercially launched its CarbonBuilder seed inoculum and SecondCrop carbon project offering to Australian farmers, moving from pre-commercial to commercial.
Series A led by Time Ventures, the fund set up by Marc Benioff, with participation from the Clean Energy Finance Corporation, Main Sequence, Acre Venture Partners, Grok Ventures, Horizons Ventures, Lowercarbon Capital and Thistledown Capital.
$30M source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Loam Bioloambio.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Loam Bio do?
- Loam Bio develops fungal seed treatments that help broadacre crops store stable carbon in agricultural soils.
- Who are Loam Bio's investors?
- Loam Bio's investors include Acre Venture Partners, Artesian, HAWKTAIL, Horizons Ventures, LOWERCARBON, Lowercarbon Capital, Main Sequence Ventures, NSW Clean Technology Innovation Grants and 3 more.
- How much funding has Loam Bio raised?
- Loam Bio has disclosed $73M raised across 1 of its 3 known rounds.



